NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Acacia Research Corporation (Nasdaq: ACTG - News) today reported results for the three months ended September 30, 2009.
“Acacia Research generated $16,831,000 in licensing transactions in the third quarter of 2009, resulting in third quarter license fee revenues of $12,831,000, a decrease of 7%, compared to $13,796,000 in the year ago period, and deferred revenues of $4,000,000 which will be recognized as revenues in subsequent periods,” commented Acacia Research Chairman and CEO, Paul Ryan.
“Acacia Research trailing 12-month revenues were $58,779,000, an increase of 40%, compared to $41,963,000 at the end of the third quarter of 2008.”
“Acacia Research reported a net loss of $4,775,000, or $.16 per share, including non-cash patent amortization and non-cash stock compensation charges totaling $2,717,000. In preparation for a number of trials scheduled for later this year and in 2010, our subsidiaries increased legal expenses by $2.4 million, compared to the year ago period. This included payments for third party experts and for expert damage reports that will be used in trials. In the third quarter, Acacia generated revenues from 36 new licensing agreements, covering 18 different technologies, including initial revenues from three new licensing programs. Acacia has now generated revenues from 56 different technologies.”
“During the quarter, Acacia acquired control of 9 new patent portfolios for future licensing and controls over 125 patent portfolios. Acacia invested $8.8 million in acquiring patent portfolios, with a contractual guarantee for Acacia to receive a minimum of $5.0 million in net proceeds. The majority of the remaining acquisition costs are subject to advance royalty recovery provisions, providing for higher percentage returns to our operating subsidiaries until the advances are fully recovered and generally provide for higher percentage returns overall.”
“We currently have the largest number of licensing opportunities in our history and our track record of licensing success is generating new partnering opportunities with technology companies, universities, and research centers wanting us to partner with them and take over the licensing of their patented technologies,” concluded Mr. Ryan.
Acacia Research Corporation Consolidated Financial Results
For the Three Months Ended September 30, 2009 and 2008
License fee revenues for the third quarter of 2009 were $12,831,000, as compared to $13,796,000 in the third quarter of 2008. In addition, deferred license fee revenues, representing upfront license fee payments received or receivable from licensees at the beginning of the contractual license term, which are deferred and amortized in the statement of operations as license fee revenues on a straight-line basis over the applicable license term, increased to $6,982,000 as of September 30, 2009, compared to $318,000 at December 31, 2008.
Revenues for the third quarter of 2009 included license fees from 36 new licensing agreements covering 18 of our technology licensing programs, including initial license fee revenues for our Lighting Ballast technology, Microprocessor technology, and our Online Promotion technology. License fee revenues in the third quarter of 2009 also included fees from the licensing of our DMT® technology, Telematics technology, Pop-up Internet Advertising technology, Audio Communications Fraud Detection technology, Picture Archiving & Communication Systems technology, Projector technology, Rule Based Monitoring technology, Encrypted Media & Playback Devices technology, Heated Surgical Blades technology, Credit Card Fraud Protection technology, Remote Management of Imaging Devices technology, Database Access technology, Vehicle maintenance technology, Storage Technology and Online Auction Guarantee technology. To date, on a consolidated basis, our operating subsidiaries have generated revenues from 56 technology licensing programs.
Consolidated trailing twelve-month revenues totaled $58.8 million as of September 30, 2009, as compared to $59.7 million as of June 30, 2009, $51.8 million as of March 31, 2009, $48.2 million as of December 31, 2008, and $42.0 million at September 30, 2008.
Acacia Research Corporation reported a third quarter 2009 net loss of $4,775,000, compared to a net loss of $2,420,000 in the third quarter of 2008. Results from operations for the third quarter of 2009 included non-cash charges totaling $2,717,000, comprised of non-cash stock compensation charges of $1,472,000 and non-cash patent amortization charges of $1,245,000. Results from operations for the third quarter of 2008 included non-cash charges of $3,101,000, comprised of non-cash stock compensation charges of $1,949,000 and non-cash patent amortization charges of $1,152,000.
Marketing, general and administrative expenses for the third quarter of 2009 decreased to $5,089,000 (including non-cash stock compensation charges of $1,472,000) from $5,464,000 (including non-cash stock compensation charges of $1,949,000) in the comparable 2008 period, primarily due to a decrease in non-cash stock compensation charges resulting from a reduction in personnel since the end of the prior year period and a decrease in the average fair value of equity-based incentive awards expensed in the third quarter of 2009, as compared to the prior year period. The decrease was partially offset by a minor increase in general and administrative expenses related to ongoing operations.
Inventor royalties expenses for the third quarter of 2009 and 2008 were $3,010,000 and $4,329,000, respectively. Contingent legal fees expenses for the third quarter of 2009 and 2008 were $3,470,000 and $3,934,000, respectively. In addition, net income attributable to noncontrolling interests in operating subsidiary, representing the portion of net proceeds from the licensing and enforcement activities of a majority-owned operating subsidiary that are distributable to the operating subsidiary’s noncontrolling interest holders pursuant to the underlying operating agreement, totaled $1,029,000 in the third quarter of 2009. The economic terms of the inventor agreements, operating agreements and contingent legal fee arrangements, if any, including royalty rates, contingent fee rates and other terms, vary across the patent portfolios owned or controlled by our operating subsidiaries. As such, inventor royalties, payments to noncontrolling interests and contingent legal fees expenses fluctuate period to period, based on the amount of revenues recognized each period and the mix of specific patent portfolios with varying economic terms generating revenues each period.
In the aggregate, inventor royalties and noncontrolling interests in operating subsidiary decreased 7% during the third quarter of 2009, as compared to the third quarter of 2008, consistent with the 7% decrease in license fee revenues for the same periods. Contingent legal fees expenses decreased 12% for the same periods, due to certain patent portfolios with lower contingent fee rates generating revenues during the third quarter of 2009, as compared to the patent portfolios generating revenues in the comparable 2008 period.
Patent-related legal expenses for the third quarter of 2009 were $3,536,000, as compared to $1,110,000 in the third quarter of 2008. Patent-related legal expenses include patent-related prosecution and enforcement costs incurred by outside patent attorneys engaged on an hourly basis and the out-of-pocket expenses incurred by law firms engaged on a contingent fee basis. Patent-related legal expenses fluctuate from period to period based on patent enforcement and prosecution activity associated with ongoing licensing and enforcement programs and the timing of the commencement of new licensing and enforcement programs in each period. The increase in patent-related legal expenses is due to an increase in litigation support related out of pocket expenses, third party technical consulting expenses and professional expert expenses incurred in connection with our continued investment in certain of our licensing and enforcement programs with trial dates scheduled for late 2009 and early 2010, and a net increase in costs related to new licensing and enforcement programs commenced since the end of the prior year period. We expect patent-related legal expenses to continue to fluctuate period to period based on the factors summarized above, in connection with upcoming scheduled trial dates and our current and future patent acquisition, development, licensing and enforcement activities.
Patent-related research, consulting and other expenses for the third quarter of 2009 were $404,000, as compared to $444,000 in the third quarter of 2008. Research, consulting and other expenses include third-party patent related research, development, consulting, licensing and enforcement and patent maintenance costs incurred in connection with the development, licensing and enforcement and maintenance of patent portfolios. These costs fluctuate period to period based on patent licensing and enforcement activities in each period.
Investments in Patent Portfolios
During the three months ended September 30, 2009, certain of our operating subsidiaries continued to execute their business strategy in the area of patent portfolio acquisitions. Patent portfolio acquisition costs for the three months ended September 30, 2009 totaled $8.8 million, as compared to $100,000 during the comparable 2008 period. During the three months ended September 30, 2009, we acquired a total of nine patent portfolios, with applications in the digital video enhancement, communications messaging, records management, power management, biosensors, integrated access, data synchronization between mobile and fixed computer systems, and other technology areas. The total number of patents and associated U.S. applications per portfolio acquired during the three months ended September 30, 2009 ranged from one to 49. Several of the patent portfolios acquired in the third quarter of 2009 were acquired in connection with partnering arrangements executed with major technology companies, reflecting our continued identification of opportunities to partner not only with individual inventors and small to medium size technology companies, but also major well established technology companies with larger patent portfolios.
Of the $8.8 million in patent acquisition costs invested during the third quarter of 2009, we have a contractual guarantee to receive a minimum of $5.0 million in net proceeds, which significantly reduces the risk associated with these initial investments. The majority of remaining acquisition costs incurred are subject to contractual provisions providing for higher percentage returns to our operating subsidiaries early on in the licensing and enforcement program until such initial upfront acquisition costs are fully recovered.
The higher level of acquisition costs incurred in the current quarter reflects our continued identification of opportunities to partner with major technology companies and exchange up front, advanced royalty payments to patent owners, for a reduced future inventor royalty percentage, resulting in the potential for higher returns on our investments for our shareholders, in connection with future licensing and enforcement activities.
Financial Condition
Total assets were $76,074,000 as of September 30, 2009 compared to $73,074,000 as of December 31, 2008. Cash and cash equivalents and investments totaled $45,284,000 as of September 30, 2009 compared to $51,518,000 as of December 31, 2008. During the nine months ended September 30, 2009, patent related acquisition costs totaled $9,162,000, as compared to $1,759,000 during the comparable 2008 period.
Refer to the section below entitled “Summary Financial Information” for summary consolidated balance sheet, income statement and cash flow information as of and for the three and nine months ended September 30, 2009.
Business Highlights and Recent Developments
Business highlights of the third quarter and recent developments include the following:
(Note: Acacia Patent Acquisition LLC, Financial Systems Innovation LLC, Lighting Ballast Control LLC, Hospital Systems Corporation, Light Valve Solutions LLC, International Printer Corporation, Data Network Storage LLC, Optimum Processing Solutions LLC, Microprocessor Enhancement Corporation, Diagnostic Systems Corporation, Service Reminder LLC, Thermal Scalpel LLC, Internet Coupon Solutions LLC and Creative Internet Advertising Corporation are all wholly owned operating subsidiaries of Acacia Research Corporation):
|
|
The expired patent asserted in this litigation generally relates to a computerized system for protecting retailers and consumers engaged in credit card, check card, and debit transactions. The system includes an electronic card reader, and the generation and use of a transaction number, which specifically identifies each transaction processed within the system.
A conference call is scheduled for today. The Acacia Research presentation and Q&A will start at 1:30 p.m. Pacific Time (4:30 p.m. Eastern).
To listen to the presentation by phone, dial (888) 646-0797 for domestic callers and (706) 758-8573 for international callers, both of whom will need to enter the conference ID 29015115 when prompted. A replay of the audio presentation will be available for 30 days at (800) 642-1687 for domestic callers and (706) 645-9291 for international callers, both of whom will need to enter the Conference ID 29015115 when prompted.
The call is being webcast by CCBN and can be accessed at Acacia’s website at www.acaciaresearch.com.
ABOUT ACACIA RESEARCH CORPORATION
Acacia Research’s subsidiaries develop, acquire, and license patented technologies. Acacia Research’s subsidiaries control over 125 patent portfolios, which include U.S. patents and certain foreign counterparts, covering technologies used in a wide variety of industries.
Information about Acacia Research is available at www.acaciatechnologies.com and www.acaciaresearch.com.
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995
This news release contains forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. These statements are based upon our current expectations and speak only as of the date hereof. Our actual results may differ materially and adversely from those expressed in any forward-looking statements as a result of various factors and uncertainties, including the recent economic slowdown affecting technology companies, our ability to successfully develop products, rapid technological change in our markets, changes in demand for our future products, legislative, regulatory and competitive developments and general economic conditions. Our Annual Report on Form 10-K, recent and forthcoming Quarterly Reports on Form 10-Q, recent Current Reports on Forms 8-K and 8-K/A, and other SEC filings discuss some of the important risk factors that may affect our business, results of operations and financial condition. We undertake no obligation to revise or update publicly any forward-looking statements for any reason.
|
ACACIA RESEARCH CORPORATION SUMMARY FINANCIAL INFORMATION (In thousands, except share and per share information) (Unaudited) |
||||||||
|
|
||||||||
|
CONDENSED CONSOLIDATED BALANCE SHEET INFORMATION |
||||||||
|
|
||||||||
|
September 30, |
December 31, |
|||||||
| 2009 | 2008 | |||||||
| ASSETS | ||||||||
| Current assets: | ||||||||
| Cash and cash equivalents | $ | 42,800 | $ | 48,279 | ||||
| Accounts receivable | 6,535 | 7,436 | ||||||
| Deferred royalties and contingent legal fees | 2,398 | - | ||||||
| Prepaid expenses and other current assets | 1,512 | 1,255 | ||||||
| Total current assets | 53,245 | 56,970 | ||||||
| Property and equipment, net of accumulated depreciation | 186 | 221 | ||||||
| Patents, net of accumulated amortization | 18,211 | 12,419 | ||||||
| Investments - noncurrent | 2,484 | 3,239 | ||||||
| Other assets | 1,948 | 225 | ||||||
| $ | 76,074 | $ | 73,074 | |||||
| LIABILITIES AND STOCKHOLDERS' EQUITY | ||||||||
| Current liabilities: | ||||||||
| Accounts payable and accrued expenses | $ | 5,766 | $ | 3,240 | ||||
|
Royalties and contingent legal fees payable |
8,733 | 10,770 | ||||||
| Deferred revenues | 4,580 | 318 | ||||||
| Total current liabilities | 19,079 | 14,328 | ||||||
| Deferred revenues, net of current portion | 2,402 | - | ||||||
| Other liabilities | 246 | 199 | ||||||
| Total liabilities | 21,727 | 14,527 | ||||||
| Total stockholders' equity | 54,347 | 58,547 | ||||||
| $ | 76,074 | $ | 73,074 | |||||
|
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS |
||||||||||||||||||
|
|
||||||||||||||||||
|
For the Three Months Ended |
For the Nine Months Ended |
|||||||||||||||||
| September 30, 2009 | September 30, 2008 | September 30, 2009 | September 30, 2008 | |||||||||||||||
| License fee revenues | $ | 12,831 | $ | 13,796 | $ | 40,512 | $ | 29,960 | ||||||||||
| Operating costs and expenses: (1) | ||||||||||||||||||
| Cost of revenues: | ||||||||||||||||||
| Inventor royalties | 3,010 | 4,329 | 8,890 | 8,596 | ||||||||||||||
| Contingent legal fees | 3,470 | 3,934 | 9,890 | 8,503 | ||||||||||||||
| Legal expenses - patents | 3,536 | 1,110 | 7,000 | 3,111 | ||||||||||||||
| Research, consulting and other expenses - patents | 404 | 444 | 1,350 | 1,555 | ||||||||||||||
| Amortization of patents | 1,245 | 1,152 | 3,370 | 3,731 | ||||||||||||||
| Marketing, general and administrative expenses (including non-cash stock compensation expense of $1,472 and $5,573 for the three and nine months ended September 30, 2009, respectively and $1,949 and $5,716 for the three and nine months ended September 30, 2008, respectively) | ||||||||||||||||||
| 5,089 | 5,464 | 17,076 | 17,014 | |||||||||||||||
| Total operating costs and expenses | 16,754 | 16,433 | 47,576 | 42,510 | ||||||||||||||
| Operating loss | (3,923 | ) | (2,637 | ) | (7,064 | ) | (12,550 | ) | ||||||||||
| Total other income | 224 | 255 | 558 | 685 | ||||||||||||||
| Loss from operations before provision for income taxes | (3,699 | ) | (2,382 | ) | (6,506 | ) | (11,865 | ) | ||||||||||
| Provision for income taxes | (47 | ) | (38 | ) | (124 | ) | (85 | ) | ||||||||||
|
Net loss including noncontrolling interests in operating subsidiary |
(3,746 | ) | (2,420 | ) | (6,630 | ) | (11,950 | ) | ||||||||||
| Net income attributable to noncontrolling interests in operating subsidiary | (1,029 | ) | - | (3,150 | ) | - | ||||||||||||
|
Net loss attributable to Acacia Research Corporation |
$ | (4,775 | ) | $ | (2,420 | ) | $ | (9,780 | ) | $ | (11,950 | ) | ||||||
| Net loss per common share attributable to Acacia Research Corporation: | ||||||||||||||||||
| Basic and diluted net loss per share | $ | (0.16 | ) | $ | (0.08 | ) | $ | (0.33 | ) | $ | (0.41 | ) | ||||||
| Weighted average number of shares outstanding, basic and diluted | 30,071,492 | 29,553,609 | 29,818,956 | 29,365,035 | ||||||||||||||
|
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS |
|||||||||||||||||||
|
For the Three Months Ended |
For the Nine Months Ended | ||||||||||||||||||
|
September 30, 2009 |
September 30, 2008 |
September 30, 2009 |
September 30, 2008 |
||||||||||||||||
| Net cash provided by (used in): | |||||||||||||||||||
| Operating activities | $ | (3,291 | ) | $ | (295 | ) | $ | 5,896 | $ | (4,175 | ) | ||||||||
| Investing activities | (7,947 | ) | (54 | ) | (8,232 | ) | 4,276 | ||||||||||||
|
Financing activities (2) |
(2,085 | ) | - | (3,143 | ) | 142 | |||||||||||||
| Increase (decrease) in cash and cash equivalents | (13,323 | ) | (349 | ) | (5,479 | ) | 243 | ||||||||||||
|
Cash and cash equivalents, beginning |
56,123 | 41,059 | 48,279 | 40,467 | |||||||||||||||
| Cash and cash equivalents, ending | $ | 42,800 | $ | 40,710 | $ | 42,800 | $ | 40,710 | |||||||||||
|
|
|||||||||||||||||||
Note:
| (1) - | Certain operating costs and expenses previously reported for the three and nine months ended September 30, 2008 have been reclassified to conform with the current period presentation. |
| (2) - |
Includes $2,121,000 in payments to noncontrolling interests in operating subsidiary. |
Acacia Research Corporation
Rob Stewart
Investor Relations
Tel 949-480-8300
Fax 949-480-8301
Copyright © 2009 Business Wire. All rights reserved. All the news releases provided by Business Wire are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials by posting, archiving in a public web site or database, or redistribution in a computer network is strictly forbidden.